变态另类zoz0另类,在线精品亚洲一区二区,无码精品黑人一区二区三区,四虎影视无码永久免费无码

Technology platform
Innovation, technology, integration and sharing
Animal Health Product R&D Center

The animal health product R&D center is operated by Hangzhou Bairun Testing Co., Ltd., a subsidiary of Hangzhou Baicheng Pharmaceutical. Relying on Baicheng Pharmaceutical's powerful multi-dosage technology center and platform, it focuses on the research and development of animal drugs and can provide partners with the following services:

1. We can develop human-to-pet drugs, chemical generic drugs (preparations and APIs), Chinese veterinary drug preparations, innovative veterinary drugs, etc.


2. We can develop dosage forms covering tablets (including sustained-release preparations, regular tablets and chewable tablets, etc.), granules, oral solutions, liquid insecticides, ointments and creams, sprays, injections, injections ( Including solution type, suspension type and freeze-dried) and other dosage forms.


3. We can provide partners with integrated solution support for pharmaceutical research on veterinary drugs (including conventional pharmaceutical research, early research on innovative veterinary drugs, research on raw materials, excipients, preparations and other fields of generic drugs and innovative veterinary drugs), registration and application, etc. Until the new veterinary drug certificate and veterinary drug product approval number are obtained, it will help veterinary drug manufacturers stand out in domestic competition and become a leading domestic enterprise that can compete with international giants such as Boehringer, Merck, and Eli Lilly.

Welcome to inquire! Contact: Mr. Tang, 19357662295

Veterinary Drug Types
Pet Medicine/Veterinary Medicine

You are welcome to contact us via the online form below.

We will answer your inquiries in various ways, and jointly provide customized professional consultation and solutions for your research and development needs.

What information and information do you want to know?
General consultation
Business consulting
Media and investment
Content of your inquiry
name
email
telphone
address
code